Cargando…

Cancer Treatment in CKD: Time to Move Beyond Renalism

Detalles Bibliográficos
Autores principales:	Berger, Joseph Rossi, Vazquez, Miguel Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547220/ https://www.ncbi.nlm.nih.gov/pubmed/37768807 http://dx.doi.org/10.34067/KID.0000000000000258

Ejemplares similares

Palliative Care for Patients With Advanced CKD: Moving Beyond the Status Quo
por: Lu, Emily, et al.
Publicado: (2019)

Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary Care
por: Joshi, Priya, et al.
Publicado: (2022)

Care programme approach – time to move beyond?
por: Kingdon, David
Publicado: (2019)

Moving beyond COVID
por: Tandon, Rajiv
Publicado: (2022)

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?
por: Silkensen, Shannon L., et al.
Publicado: (2018)

Cancer immunotherapy: Moving beyond checkpoint inhibition
por: Boes, Marianne
Publicado: (2018)

Diagnostic errors: moving beyond ‘no respect’ and getting ready for prime time
por: Singh, Hardeep
Publicado: (2013)

Comparing alcohol with tobacco indicates that it is time to move beyond tobacco exceptionalism
por: McCambridge, Jim, et al.
Publicado: (2019)

EUS-guided biliary drainage: Moving beyond the cliché of prime time
por: Dhir, Vinay, et al.
Publicado: (2019)

Life after death: RIP1 and RIP3 move beyond necroptosis
por: Berger, SB, et al.
Publicado: (2016)

COVID‐19: Moving beyond the pandemic
por: McPeake, Joanne, et al.
Publicado: (2020)

It’s Time to Move Beyond Traditional Health Care Worker Training Approaches
por: Bluestone, Julia, et al.
Publicado: (2021)

Nosocomial Meningitis: Moving beyond Description to Prevention
por: Kim, Hong Bin
Publicado: (2012)

Effective LARC Providers: Moving Beyond Training
por: Shelton, James D, et al.
Publicado: (2016)

Effective LARC Providers: Moving Beyond Training (Republication)
por: Shelton, James D, et al.
Publicado: (2016)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?
por: Beeh, Kai M.
Publicado: (2018)

Concussion research: Moving beyond the natural history
por: Buckley, Thomas A.
Publicado: (2021)

Wildlife, Reservoir of Zoonotic Agents: Moving beyond Denial and Fear
por: Davoust, Bernard, et al.
Publicado: (2023)

Telehealth and Management Support for Hypertension in CKD: Time to Raise the Bar
por: Okpechi, Ikechi G., et al.
Publicado: (2023)

Radiomics for prediction of survival in lower-grade gliomas—it’s time to move beyond the crystal ball
por: Pinto dos Santos, Daniel, et al.
Publicado: (2020)

Time to move to open access
por: Allebeck, Peter, et al.
Publicado: (2021)

The Neglected Diseases Section in PLoS Medicine: Moving Beyond Tropical Infections
Publicado: (2008)

Successful recovery after major surgery: moving beyond length of stay
por: Miller, Timothy E, et al.
Publicado: (2014)

Tuberculosis diagnostic networks: Moving beyond the laboratory to end tuberculosis in Africa
por: Piatek, Amy
Publicado: (2017)

Dynamism of the Human Lung Proteome during Alveolarization: Moving beyond the Transcriptome
por: Alvira, Cristina M.
Publicado: (2021)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Moving Beyond PM(2.5) Mass to More Effectively Protect Health
por: Thurston, George D.
Publicado: (2023)

Moving Beyond the Mouse: Key New Insight Into Human Colonic Dendritic Cells
por: Denning, Timothy L.
Publicado: (2015)

Moving Beyond the Confines of Body Mass Index in the Quest to Understand Obese Asthma
por: Forno, Erick
Publicado: (2020)

Urban health: it's time to get moving!
por: Barbiero, Victor K
Publicado: (2014)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Anticoagulation in CKD: Trials and Tribulations
por: Mohsen, Mai, et al.
Publicado: (2023)

Probiotics in CKD: waiting for the evidence
por: Campos, Letícia Fuganti
Publicado: (2023)

Obesity Indices and the Risk of CKD
por: Tsuboi, Nobuo
Publicado: (2021)

Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys
por: Waters, David D.
Publicado: (2021)

Understanding Sex-based Differences in Intensive Care Unit Mortality: Moving Beyond the Biology
por: Viglianti, Elizabeth M., et al.
Publicado: (2022)

Libyan Medical Education; Time to Move Forward
por: Daw, MA, et al.
Publicado: (2008)

Exercise for Health and Disease: Time to Move Ahead
por: Gentil, Paulo, et al.
Publicado: (2017)

Surveillance for hepatocellular carcinoma: It is time to move forward
por: Kim, Bo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88bh31itbbbg763uevkahpelic